Dr Agarwals Healthcare Share Price Opens at ₹402 on Listing Day, Feb 4

Dr Agarwals Healthcare IPO opened for subscription on January 29, 2025, and closed on January 31, 2025.
It was a book-built issue of ₹3,027.26 crore. The issue was a combination of a fresh issue of 0.75 crore shares and an offer for sale of 6.78 crore shares. The Dr Agarwals Healthcare IPO price band was set at ₹382 to ₹402 per share.
On Day 3 of subscription, January 31, as of 5:04 PM, Dr Agarwals Healthcare IPO was subscribed 1.49 times. QIBs subscribed 4.41x, NIIs subscribed 0.39x, and retail investors subscribed 0.42x.
The share allotment was finalised on Monday, February 3, 2025, and the shares were listed on BSE and NSE on Tuesday, February 4, 2025.
Dr Agarwals Healthcare Share Price
On the listing day, on the NSE, Dr Agarwals Healthcare share price (NSE: AGARWALEYE) opened at ₹402.00, the same as its issue price of ₹402.00. The share price closed at ₹400.00, down by 0.50%. The stock touched its day’s high at ₹412.90 and day’s low at ₹370.20. The company’s market cap was ₹12,635.19 crore.
On the BSE, Dr Agarwals Healthcare share price closed at ₹401.55, up by 1.17%. The opening price was ₹396.90.
About Dr. Agarwal’s Health Care Limited
Dr Agarwals provides a comprehensive range of eye care services, such as cataract, refractive, and other surgeries. The company also provides consultations, diagnoses, non-surgical treatments, optical products, contact lenses, accessories, and eye care-related pharmaceutical products.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 5, 2025, 8:54 AM IST

Nikitha Devi
Nikitha is a content creator with 6+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know More- CCI Clears Creation of JV Company Between Mercuria Energy Netherlands and Tata International Singapore
- Jindal India Completes ₹1,500 Crore Expansion Project in West Bengal with New Coating Facility
- Consumer Goods Makers Including Hindustan Unilever and Dabur Expect Volume Led Growth as Inflation Eases
- Zensar Technologies Final Dividend Record Date on July 11: What It Means for Shareholders?
- UltraTech Cement Eyes Acquisition of HeidelbergCement India




